These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8765089)

  • 21. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter.
    Lesch KP; Wolozin BL; Murphy DL; Reiderer P
    J Neurochem; 1993 Jun; 60(6):2319-22. PubMed ID: 7684072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes.
    Lips JP; Sixma JJ; Schiphorst ME
    Biochim Biophys Acta; 1980 Apr; 628(4):451-67. PubMed ID: 6245712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
    Brass LF; Shattil SJ
    J Clin Invest; 1984 Mar; 73(3):626-32. PubMed ID: 6231306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
    Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
    Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD.
    Marazziti D; Masala I; Rossi A; Hollander E; Presta S; Giannaccini G; Mazzoni MR; Dell'Osso L; Lucacchini A; Cassano GB
    Neuropsychobiology; 2000; 41(4):171-7. PubMed ID: 10828725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet phospholipid methylation during platelet secretion.
    Shattil SJ; McDonough M; Burch JW
    Blood; 1981 Mar; 57(3):537-44. PubMed ID: 6779878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet serotonin transporter.
    Rudnick G; Humphreys CJ
    Methods Enzymol; 1992; 215():213-24. PubMed ID: 1435323
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
    Rudnick G; Wall SC
    Mol Pharmacol; 1993 Feb; 43(2):271-6. PubMed ID: 8429828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin transporter kinetics in rats selected for extreme values of platelet serotonin level.
    Cicin-Sain L; Froebe A; Bordukalo-Niksic T; Jernej B
    Life Sci; 2005 Jun; 77(4):452-61. PubMed ID: 15894014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of a novel allosteric modulator (SoRI-6238) of the serotonin transporter.
    Nandi A; Dersch CM; Kulshrestha M; Ananthan S; Rothman RB
    Synapse; 2004 Sep; 53(3):176-83. PubMed ID: 15236350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake.
    Franke L; Schewe HJ; Müller B; Campman V; Kitzrow W; Uebelhack R; Berghöfer A; Müller-Oerlinghausen B
    Life Sci; 2000 Jun; 67(3):301-15. PubMed ID: 10983874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin transporter-blocking properties of nefazodone assessed by measurement of platelet serotonin.
    Narayan M; Anderson G; Cellar J; Mallison RT; Price LH; Nelson JC
    J Clin Psychopharmacol; 1998 Feb; 18(1):67-71. PubMed ID: 9472845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
    Savi P; Laplace MC; Maffrand JP; Herbert JM
    J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.